A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model

Cenksoy C., Cenksoy P., ERDEM O. A. , Sancak B., Gursoy R.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol.174, pp.86-90, 2014 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 174
  • Publication Date: 2014
  • Doi Number: 10.1016/j.ejogrb.2013.12.001
  • Journal Name: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.86-90
  • Keywords: OHSS, Prevention, VEGF, V1a receptor antagonist, Relcovaptan, ENDOTHELIAL GROWTH-FACTOR, SMOOTH-MUSCLE-CELLS, HORMONE AGONIST, CAPILLARY-PERMEABILITY, VASCULAR-PERMEABILITY, MOLECULAR-CLONING, EXPRESSION, RECEPTOR, PREVENTION, RISK

Abstract

Objective: To investigate the effects of VIA receptor antagonist through inhibition of vasopressin-induced, VEGF secretion in an experimental model.